Eagle Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Eagle Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,161	Closed	-$70K	–	617
2022 Q1	$70K	Hold	17,161	–	–	﹤0.01%	569
2021 Q4	$61K	Hold	17,161	–	–	﹤0.01%	589
2021 Q3	$62K	Buy	17,161 +5,845	+52%	+$23.6K	﹤0.01%	584
2021 Q2	$49K	Buy	11,316 +7	+0.1%	+$29	﹤0.01%	593
2021 Q1	$46K	Sell	11,309 -5,050	-31%	-$21.9K	﹤0.01%	589
2020 Q4	$65K	Sell	16,359 -1,906	-10%	-$6.17K	﹤0.01%	536
2020 Q3	$49K	Buy	18,265 +6,263	+52%	+$17.3K	﹤0.01%	564
2020 Q2	$32K	Buy	+12,002	New	+$33.5K	﹤0.01%	563

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eagle Asset Management's ATRS Position: Q2 2022 in Review

Eagle Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 17,161 shares — an estimated $70K sold.

Eagle Asset Management first reported a position in ATRS in Q2 2020 and held it in 8 quarters. The position peaked at $70K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Eagle Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Eagle Asset Management sold 17,161 Antares Pharma, Inc. shares in Q2 2022, an estimated $70K.
Eagle Asset Management first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 8 quarters.
Eagle Asset Management's Antares Pharma, Inc. position peaked at $70K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Eagle Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.